POMPANO BEACH, Fla., Feb. 06, 2018 -- GoooGreen, Inc., (OTCPK: GOOO) announced the company, with board approval, has signed a letter of intent, subject to finalization of due diligence, to acquire Visita Skin Care products. GoooGreen’s proposed new Visita division will begin operating a cosmetic and skin care entity with the intent of converting it into a wholly owned subsidiary under the GoooGreen umbrella. Closing is expected to be concluded within 120 days. The company is in the selection process of a production and fulfillment facility for Visita’s cosmetics and skin care product line.
Brief Description:
Visita developed and hold the formulation rights to a Skin Treatment Lotion and Cleanser for persons affected by skin conditions: psoriasis and atopic dermatitis, eczema and pruritus. The markets for psoriasis and atopic dermatitis are large. Atopic dermatitis is a type of eczema, an inflammatory pruritus, chronically relapsing, non-contagious skin disorder. Together these two diseases affect as much as 20% of the population. The company believes the Visita product line will enhance shareholder value. The company’s initial due diligence research indicates this product line is consumer desirable for the compounds imbedded in the products appear to have chemical properties that are: (1) effective, (2) have little or no side effects, (3) can be used on younger patients, (4) can be used for longer periods of time, and (5) are cost efficient.
The company will be updating shareholders with ongoing updates and details as appropriate. Further information about the Vista acquisition is expected to be announced over the next months.
Safe Harbor Provision
This news release includes forward-looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty. Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties and events that may be beyond the control of GoooGreen, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete projects, the availability of technical personnel, changes in technology and competition.
Contact: Thomas Terwillliger CEO GoooGreen, Inc. HQ@GoooGreen, Inc. 954-908-3366


Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Washington Post Publisher Will Lewis Steps Down After Layoffs 



